These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7483195)

  • 1. [Results of the use of vasoactive preparation pikamilon in pigmented retinal abiotrophy].
    Davydova GA; Mukha AI
    Vestn Oftalmol; 1995; 111(3):20-2. PubMed ID: 7483195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Time course of bioelectrical activity of retina in patients with pigmented abiotrophy treated by deoxinate].
    Tsapenko IV; Riabina MV; Zueva MV; Eliseeva RF; Katsnel'son LA
    Vestn Oftalmol; 1999; 115(4):24-6. PubMed ID: 10523963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenetic treatment of central chorioretinal dystrophies with pikamilon].
    Basinskiĭ SN; Krasnogorskaia VN; Lenis IuA
    Vestn Oftalmol; 2001; 117(2):42-4. PubMed ID: 11510167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of pikamilon use in the treatment of patients with open-angle glaucoma].
    Kolomoĭtseva EM; Ermakova VN; Abdulkadyrova MZh
    Vestn Oftalmol; 1994; 110(4):4-7. PubMed ID: 7871655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the preliminary results of the use of hyperbaric oxygenation in ocular pathology].
    Algan B; Benichoux R; Marchal H
    Bull Soc Belge Ophtalmol; 1973 Feb; 163(2):183-94. PubMed ID: 4758854
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment results using the preparation ENKAD in patients with peripheral tapetoretinal abiotrophy].
    Katsnel'son LA; Maslova-Khoroshilova IP; Eliseeva RF; Dnestrova GI
    Vestn Oftalmol; 1988; 104(6):54-61. PubMed ID: 3242209
    [No Abstract]   [Full Text] [Related]  

  • 7. [Polypeptide bioregulators in the treatment of different-type abiotrophy of the retina].
    Khvatova AV; Khlebnikova OV; Meshkova GI; Tarasenkov AO; Shchuvatova EL; Stromova OV
    Vestn Oftalmol; 2005; 121(2):19-21. PubMed ID: 15881150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Time course of visual functions in patients with pigmentary retinal degeneration after surgical treatment with biomaterial "Alloplant"].
    Galimova VU
    Vestn Oftalmol; 2001; 117(3):20-3. PubMed ID: 11521429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamic findings in patients with retinitis pigmentosa].
    Wolf S; Pöstgens H; Bertram B; Schulte K; Teping C; Reim M
    Klin Monbl Augenheilkd; 1991 Nov; 199(5):325-9. PubMed ID: 1787654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method of treatment of retinitis pigmentosa/pigmentary abiotrophy.
    Katznelson LA; Khoroshilova-Maslova IP; Eliseyeva RF
    Ann Ophthalmol; 1990 May; 22(5):167-72. PubMed ID: 2369027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of macular degeneration by hydrosarpan 711].
    Le Rebeller MJ; Rougier-Houssin J
    Arch Ophtalmol Rev Gen Ophtalmol; 1971; 31(6):547-56. PubMed ID: 4255271
    [No Abstract]   [Full Text] [Related]  

  • 12. [Outcome of cataract surgery in patients with pigmentary retinal degeneration].
    Grześk M; Kałuzny J; Malukiewicz-Wiśniewska G
    Klin Oczna; 2007; 109(4-6):194-7. PubMed ID: 17725285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular manifestations of HIV infection.
    Jabs DA
    Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet.
    Dagnelie G; Zorge IS; McDonald TM
    Optometry; 2000 Mar; 71(3):147-64. PubMed ID: 10970259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of superphonoelectrophoresis on chorioretinal dystrophy].
    Gvarishvili EP; Dushin NV
    Vestn Oftalmol; 1999; 115(4):19-21. PubMed ID: 10523961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Decreased content of non-heme iron in the blood of patients with peripheral tapetoretinal abiotrophy].
    Pozdeev NV; Volkova MV; Efimova MG; Astakhov IuS; Etingof RN
    Vestn Oftalmol; 1998; 114(3):25-6. PubMed ID: 9720394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentric retinitis pigmentosa: clinicopathologic correlations.
    Milam AH; De Castro EB; Smith JE; Tang WX; John SK; Gorin MB; Stone EM; Aguirre GD; Jacobson SG
    Exp Eye Res; 2001 Oct; 73(4):493-508. PubMed ID: 11825021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between visual acuity and central retinal thickness in retinitis pigmentosa.
    Sandberg MA; Brockhurst RJ; Gaudio AR; Berson EL
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3349-54. PubMed ID: 16123439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of pantogam on visual function and hemodynamic of eyes in patients with primary open-angle glaucoma].
    Davydova NG; Borisova SA; Kolomoĭtseva EM; Abdulkadyrova MZh; Gorshkova IA; Lisitsyna SV
    Vestn Oftalmol; 2002; 118(5):3-5. PubMed ID: 12532734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.